T he c-FLIP molecule (also named CLARP, FLAME, I-FLICE, MRIT, usurpin, Casper, or CASH) plays important roles in death receptor-mediated signaling (1) (2) (3) (4) (5) (6) (7) (8) . Three isoforms of c-FLIP derived from mRNA alternative splicing have been identified in human cells: 55kD c-FLIP L , 24kD c-FLIP R , and 26kD c-FLIP S (9, 10) , whereas only c-FLIP L and c-FLIP R but not c-FLIP S are expressed in mouse cells (11) . c-FLIP L contains two death effector domains at the N terminus and an inactive caspase-like domain at the C terminus. c-FLIP S and c-FLIP R only contain two death effector domains (9 -11) . All three isoforms inhibit death receptor-induced apoptosis, or the extrinsic death pathway, by interfering with pro-caspase 8 recruitment to the adaptor protein Fas-associated death domain when overexpressed (9 -12) .
The roles of individual c-FLIP isoforms in mature T cells remain undefined as conditional deletion of c-FLIP in thymocytes prevents mature T cell development (13) . Previous studies suggested that c-FLIP L may play a role in Th cell differentiation in transgenic (Tg) 3 overexpression mouse models (14 -16) . c-FLIP L may promote or inhibit mature T cell death given that c-FLIP L can also promote pro-caspase 8 activation at low levels of expression (17) (18) (19) (20) (21) . The roles of c-FLIPs (c-FLIP R in mouse) in mature T cells are controversial. For example, one report showed that overexpression of c-FLIP S/R decreases mature T cell survival in mouse (22) , whereas another report using a similar system did not observe decreased T cell survival (23) . Given these conflicting results, it is essential to assess the roles of endogenous c-FLIP in mature T cells using loss-of-function models. In this report, we have generated mouse models lacking c-FLIP or its individual isoforms in mature T cells. We show that the in vivo function of c-FLIP (c-FLIP L and c-FLIP R ) is to protect mature T cells from death receptor-induced apoptosis. Importantly, we found that c-FLIP protects mature T cells from TCR-induced and spontaneous apoptosis. Thus, these results indicate that c-FLIP functions beyond the extrinsic death pathway.
Materials and Methods

Mice c-FLIP
f/f mice and c-FLIP R (previously termed c-FLIP S ) bacterial artificial chromosome (BAC) Tg mice were generated in our laboratory as described (13, 24) . To generate c-FLIP L BAC Tg mice, a mouse c-FLIP wild-type BAC DNA clone was modified using a system as described (25) . In brief, mouse c-FLIP L cDNA, including its own stop codon and poly(A) signal, was fused to the start codon in exon 1 of the c-FLIP gene. A 60kb BAC fragment that is 15kb downstream of the nearest 5Ј gene (Als2cr12) and 10kb upstream of the nearest 3Ј gene (caspase 8) was used for injection. Three founders were obtained for each line and crossed to c-FLIP f/f ER-Cre mice, and all mice displayed a similar phenotype. Animal usage was conducted according to protocols approved by the Duke University Institutional Animal Care and Use Committee.
Fluorescence-labeled cell permeable caspase 8 inhibitor (FAM-LETD-FMK from Immunochemistry Technologies) was added to the culture during the last hour of incubation according to the manufactory instruction. Cells were surface stained and analyzed by flow cytometry.
Flow cytometric analysis
Cells were incubated with an FcR blocker (2.4G2; eBioscience), stained on ice for 30 min with FITC-, PE/Cy5-, or allophycocyanin-labeled mAb, and washed with PBS containing 2% FCS. A total of 1 to 5 ϫ 10 4 events were collected on a FACScan flow cytometer (BD Biosciences) and analyzed using CellQuest (BD Biosciences) or FlowJo software. All fluorescencelabeled Abs, including anti-CD4 and -CD8 were obtained from eBioscience, Biolegend, or BD Biosciences. Apoptotic cells were defined by Annexin V and 7-AAD staining using an Annexin V-PE kit (BD Biosciences).
Antibodies
Abs used for Western blots were anti-c-FLIP (clone Dave-2; Alexis Biochemical) and anti-␥-tubulin (Santa Cruz Biotechnology). cells exhibit markedly increased apoptosis upon TNF-␣ and antiFas treatment compared with control T cells ( Fig. 1B and 3A) , indicating that c-FLIP protects T cells from death receptor-induced death. After 3 days in vitro culture, 30 -40% naive T lymphocytes remained alive. To exclude the possibility that an abnormal T cell population was enriched after in vitro culture, we also performed the in vitro culture in the presence of IL-7. As expected, minimal T cell death was observed in the presence of IL-7. c-FLIP-deficient T cells from culture with or without IL-7 exhibited similar survival defect (data not shown).
Semiquantitative RT-PCR analysis
Results
Impaired survival of c-FLIP-deficient mature T lymphocytes after death receptor engagement
Impaired survival of c-FLIP-deficient T cells after TCR engagement
As TCR signaling induces caspase 8 activation (28, 29) and c-FLIP can either promote or inhibit caspase 8 activation (10, (17) (18) (19) , and c-FLIP-deficient T cells have been found to have increased apoptosis following TCR stimulation in a Rag chimeric mutant model (30) , we tested what roles c-FLIP might play after TCR stimulation of mature T cells in an ER-cre inducible system. We stimulated mature T cells that were deleted of c-FLIP in vitro with anti-CD3. Remarkably, TCR stimulation induced the death of 60 -90% of CD4 ϩ and CD8 ϩ c-FLIP-deficient T cells (Fig. 1, B and C) . Since it is possible that naive T cells could be more sensitive to tamoxifen-induced toxicity than activated cells, resulting in a cell population enriched for activated cells that would undergo activationinduced cell death upon TCR stimulation, we examined wild-type and c-FLIP f/f ER-cre T cells cultured for 3 days with and without tamoxifen. We saw no differences in the activation profile (CD62L and CD44 expression) in cells treated with or without tamoxifen, indicating that the results we see are due to a defect in T cell survival following initial TCR stimulation in c-FLIP-deficient cells (data not shown). Interestingly, c-FLIP Ϫ/Ϫ T cells also exhibit a slightly but significantly elevated apoptotic rate without any stimuli (Fig. 1, B and C) . It should be noted that in the absence of anti-CD3 stimulation, T cells were still in the resting stage after in vitro culture as determined by CD25 and CD69 staining (data not shown). These results suggest that c-FLIP regulates the survival of both resting and activated T cells. We then tested whether caspase 8 activity is enhanced in c-FLIP Ϫ/Ϫ T cells. One day after 4OH-tamoxifen induced deletion, c-FLIP f/f ER-Cre T cells exhibited comparable caspase 8 activity as wild-type T cells due to the incomplete deletion of c-FLIP at this time point (Fig. 1, A and D) . However, when c-FLIP deletion was completed at day 3, c-FLIP Ϫ/Ϫ T cells exhibited a 33% increase (17.3 vs 23.1%) without TCR stimulation and a 78% increase (20 vs 35.6%) with TCR stimulation in the percentage of cells containing active caspase 8 during a 5-h culture (Fig. 1D) . Furthermore, addition of benzyloxycarbonyl-Val-Ala-Asp (zVAD) restored the survival defects in c-FLIP Ϫ/Ϫ T cells with or without TCR stimulation (Fig. 2, A and  B) , suggesting that these cells die by apoptosis. These results suggest that c-FLIP plays a critical role in the survival of resting and activated T cells likely through the inhibition of caspase 8 activation.
Both c-FLIP L and c-FLIP R isoforms protect T cells from death
Although two isoforms of c-FLIP, c-FLIP L and c-FLIP R , have been identified in mouse T cells, their function remains undetermined. It was shown that c-FLIP L inhibits caspase 8 activation at high expression levels, while it promotes caspase 8 activation at low expression levels (17) (18) (19) ). An enhanced caspase 8 activity was observed in c-FLIP L Tg T lymphocytes (20, 21) . Although c-FLIP R is considered a caspase 8 inhibitor (9 -11), its role has not been examined in mouse T lymphocytes. Furthermore, a recent report showed that overexpression of human c-FLIP S , which is very similar human c-FLIP R at both sequence and function level, promotes T cell death (22) and this result is contradictory to a previous publication (23) . Thus, it is essential to examine the role of endogenous c-FLIP L and c-FLIP R in mature T cell survival. To achieve this, we have generated conditional knockout mice lacking either isoform by crossing c-FLIP f/f ER-cre to BAC Tg mice expressing either mouse c-FLIP L or mouse c-FLIP R cDNA. As these cDNAs were inserted into the c-FLIP locus in BAC DNA, the expression of c-FLIP L or c-FLIP S in these mice is controlled by the endogenous c-FLIP promoter and regulatory elements. T lymphocytes from c-FLIP f/f ER-cre.c-FLIP L BAC Tg mice that are treated with 4OH-tamoxifen express c-FLIP L but not c-FLIP R and therefore referred to as c-FLIP R Ϫ/Ϫ T cells (Fig. 2C) . Similarly, T lymphocytes from c-FLIP f/f ER-cre.c-FLIP R BAC Tg mice that are treated with 4OH-tamoxifen express c-FLIP R but not c-FLIP L and therefore referred to as c-FLIP L Ϫ/Ϫ T cells (Fig. 2C) . Expression of either c-FLIP R or c-FLIP L in T lymphocytes was sufficient to rescue the survival defects in c-FLIP Ϫ/Ϫ T cells in the presence or absence of TCR stimulation (Fig. 2, A and B) . These data suggest that both c-FLIP R and c-FLIP L isoforms are anti-apoptotic caspase 8 inhibitors in mature T cells at endogenous expression levels. 3, A and C). In contrast, deletion of TNF-␣ had no obvious effect on the high apoptosis of c-FLIP Ϫ/Ϫ T cells (Fig. 3, B and  C) . Furthermore, c-FLIP-deficient T cells from an lpr/lpr/ TNF-␣ double-deficient background had apoptotic rates similar to those from an lpr single mutation background (Fig. 3, B and  C) . Thus, these results suggest that Fas-mediated death signaling only contribute partially to TCR-induced apoptosis in c-FLIP-deficient T cells, while TNF-mediated death signaling has no obvious role in this process.
The role of death receptors in TCR-induced apoptosis of c-FLIP
c-FLIP is critical for maintaining T cell homeostasis in vivo
To directly test whether c-FLIP is required for mature T cell survival in vivo, T cells from c-FLIP f/f ER-Cre and c-FLIP f/ϩ ER-cre mice were labeled with high or low amounts of CFSE, mixed at a 1:1 ratio, and transferred into unmanipulated wild-type hosts. Similar results were seen when host LN and spleen were analyzed, and the panel shown is from host LN. Five days after in vivo tamoxifen administration, the number of c-FLIP Ϫ/Ϫ T cells was decreased to 10 -40% of that of transferred control T cells (Fig. 4) . Thus, c-FLIP is required for T cell homeostasis in vivo.
Discussion
Although c-FLIP has been identified as a critical player in death receptor-induced signaling for more than a decade, the function of endogenous c-FLIP in mature T cells remains unclear. Conflicting results suggest that c-FLIP L might inhibit or promote mature T cell death (17-19, 22, 23) . We have generated several genetic models to investigate the function of c-FLIP in mature T cells. As expected, we found that c-FLIP protects T cells from death receptorinduced apoptosis via Fas and TNFR. However, we also found that c-FLIP protects mature T cells from TCR-induced as well as spontaneous cell death. Furthermore, both c-FLIP L and c-FLIP R isoforms function as anti-apoptotic proteins in mature T cells.
The likely target for c-FLIP in the survival of resting and TCRstimulated mature T cells is caspase 8. Caspase 8 is actively involved in T cell homeostasis. TCR signaling rapidly up-regulates caspase 8 activity (28, 29) . Considering the fact that weak TCR/ MHC interaction is required for naive T cell survival, basal caspase 8 activity may also be present in resting T lymphocytes. Indeed, c-FLIP Ϫ/Ϫ T cells exhibit a marked increase of caspase 8 activity with or without TCR stimulation. Furthermore, because c-FLIP Ϫ/Ϫ T cells exhibit enhanced spontaneous and TCR-induced apoptosis, and zVAD completely rescues both defects, c-FLIP is the essential caspase 8 inhibitor in T lymphocytes. In the absence of c-FLIP, caspase 8 activity may elevate to a harmful level even without TCR stimulation. Thus, the major function of c-FLIP in resting naive T cells is likely to prevent the constitutively low levels of active caspase 8 from killing the cells.
Our data demonstrate that c-FLIP L and c-FLIP R , when expressed at endogenous levels, inhibit apoptosis. The role of c-FLIP L in regulating caspase 8 activity and cell death has been controversial. c-FLIP L was shown to promote caspase 8 activation at low expression levels and inhibit caspase 8 activation at high expression levels (17) (18) (19) (20) (21) . Although c-FLIP R is generally considered a caspase 8 inhibitor (9 -11), recent reports showed that overexpression of c-FLIP S , which is very similar to c-FLIP R , in T cells generated conflicting results regarding T cell death (22, 23) . These controversial results are likely derived from the various overexpression systems used. By expressing the c-FLIP L or c-FLIP R isoform under its own regulatory elements, our data clearly show that both c-FLIP L and c-FLIP R are anti-apoptotic in resting and TCRstimulated mature T lymphocytes.
Our data demonstrate that the Fas/FasL interaction, but not TNF-␣, contributes only partially to the apoptosis of c-FLIP-deficient CD4 ϩ and CD8 ϩ T cells upon TCR engagement. Previous studies have demonstrated that preactivated T cells and T cell hybridoma cell lines undergo rapid apoptosis upon TCR restimulation through a Fas/FasL-or TNF-␣/TNFR-dependent mechanism (31) (32) (33) (34) (35) (36) (37) (38) (39) . However, our genetic data has clearly established that Fas does not cause all the cell death in TCR-stimulated c-FLIP-deficient T cells. Our results suggest that TCR engagement may activate caspase 8 independent of death receptors and Fas/FasL may function as an amplifier, but not an initiator, of caspase 8 activation in T lymphocytes. Although lpr mutation does not completely eliminate Fas signaling (40) , it is unlikely that the mutant Fas still delivers a critical death signal during TCR-induced cell death in our system based on three lines of evidences. First, lpr mutation completely restores the survival defects upon the anti-Fas stimulation in c-FLIP Ϫ/Ϫ T cells (Fig. 3A) . Second, extensive previous investigations have shown that lpr mutation rescues the preactivated T cells from TCR-induced apoptosis (33, 35, 36, 38, 39) . Third, in the report showing that lpr mutant is partially functional, the authors clearly demonstrated that lpr mutant completely loses the capacity to induce cell death while it can activate NF-B signaling only in heterozygous (lpr/ϩ) mice (40) . In our experiments, only lpr/lpr mice were used. Therefore, lpr mutant can be considered as a complete loss-of-function of the death inducing capacity of Fas. Since death receptor mutations partially restore and zVAD completely restores the survival defects in c-FLIP Ϫ/Ϫ T cells upon TCR stimulation, this suggests that TCR signaling induces caspase activation through a Fas-(and TNFR-) independent mechanism. Thus, c-FLIP is critically needed to protect T cells from caspase activity during resting as well as activation phases.
